228 related articles for article (PubMed ID: 35505944)
21. Current and emerging biologic therapies targeting eosinophilic disorders.
Pitlick MM; Li JT; Pongdee T
World Allergy Organ J; 2022 Aug; 15(8):100676. PubMed ID: 35983569
[TBL] [Abstract][Full Text] [Related]
22. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
[TBL] [Abstract][Full Text] [Related]
23. Eosinophilic Esophagitis: The Role of Steroids and the Dose, Duration, and Delivery of Steroid Therapy.
Ramanan SP; Singh B; Gandhamaneni SH; Sange I
Cureus; 2024 Apr; 16(4):e58343. PubMed ID: 38756322
[TBL] [Abstract][Full Text] [Related]
24. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of eosinophilic esophagitis - advancements and perspectives].
Miehlke S; Arnim UV; Schlag C; Labenz J; Madisch A
Laryngorhinootologie; 2023 May; 102(5):339-348. PubMed ID: 37141876
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilic esophagitis in adults and adolescents: epidemiology, diagnostic challenges, and management strategies for a type 2 inflammatory disease.
Savarino EV; Barbara G; Bilò MB; De Bortoli N; Di Sabatino A; Oliva S; Penagini R; Racca F; Tortora A; Rumi F; Cicchetti A
Therap Adv Gastroenterol; 2024; 17():17562848241249570. PubMed ID: 38812705
[TBL] [Abstract][Full Text] [Related]
27. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
28. A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children.
Rokkas T; Niv Y; Malfertheiner P
J Clin Gastroenterol; 2021 May-Jun 01; 55(5):400-410. PubMed ID: 32398629
[TBL] [Abstract][Full Text] [Related]
29. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
Schoepfer A; Safroneeva E; Straumann A
Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
[TBL] [Abstract][Full Text] [Related]
30. Novel Therapeutic Approaches to Eosinophilic Esophagitis.
Beveridge C; Falk GW
Gastroenterol Hepatol (N Y); 2020 Jun; 16(6):294-301. PubMed ID: 34035732
[TBL] [Abstract][Full Text] [Related]
31. New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis.
Nhu QM; Moawad FJ
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):48-62. PubMed ID: 30707411
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
Greuter T; Alexander JA; Straumann A; Katzka DA
Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
[TBL] [Abstract][Full Text] [Related]
33. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.
Andrist CM; Jörg L; Greuter T; Gschwend A; Straumann A; Helbling A
BMC Gastroenterol; 2020 Dec; 20(1):419. PubMed ID: 33308158
[TBL] [Abstract][Full Text] [Related]
34. Treatment for eosinophilic esophagitis.
Syverson EP; Hait EJ
Curr Opin Gastroenterol; 2020 Nov; 36(6):485-490. PubMed ID: 33009017
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Eosinophilic Esophagitis: Diet or Medication?
Chehade M; Aceves SS
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3249-3256. PubMed ID: 34507706
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment.
Choudhury S; Baker S
Clin Rev Allergy Immunol; 2020 Oct; 59(2):150-159. PubMed ID: 31175521
[TBL] [Abstract][Full Text] [Related]
37. Current treatment options and long-term outcomes in patients with eosinophilic esophagitis.
Lucendo AJ; Molina-Infante J
Expert Rev Clin Immunol; 2022 Aug; 18(8):859-872. PubMed ID: 35770955
[TBL] [Abstract][Full Text] [Related]
38. Current and emerging therapies for eosinophilic esophagitis.
Sher ER; Ross JA; Weine DM; Chandini Arjun A
Allergy Asthma Proc; 2022 May; 43(3):178-186. PubMed ID: 35524356
[No Abstract] [Full Text] [Related]
39. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
